Medicom Oncology Clinical Pearls Podcasts
Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant IDH2
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:04:04
- Mas informaciones
Informações:
Sinopsis
Dr. Eytan Stein provides a brief update on patients experiencing differentiation syndrome in a larger enasidenib trial, detailing the creation of a Differentiation Syndrome Review Committee.
